FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Teva Pharmaceuticals Metoclopramide Injection Recall

Metoclopramide Injection USP, 10 mg/2 mL (5 mg/mL), 25x2mL Single Dose Vials, Rx only,…

Teva Pharmaceuticals USA · Parsippany, NJ

Risk level
Class II
Reported by FDA
Mar 10, 2021
Recall ID
D-0297-2021
Check your lot numberHow we source this data

Summary

Teva Pharmaceuticals recalled Metoclopramide Injection starting Feb 15, 2021. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0297-2021 on Mar 10, 2021. Reason: Chemical contamination; Unknown brown residue adhering to the inside of one vial. Status: Terminated.

Why it was recalled

Chemical contamination; Unknown brown residue adhering to the inside of one vial.

Product description

Metoclopramide Injection USP, 10 mg/2 mL (5 mg/mL), 25x2mL Single Dose Vials, Rx only, Distributed by Teva Pharmaceuticals, USA, Inc., Parsippany, NJ Vial NDC 0703-4502-01 (vial) NDC# 0703-4502-04 (tray)

Lot numbers, UPCs & expiration codes

Lot # 31325335B, exp. date 07/2021

Where it was sold

Nationwide, including Puerto Rico

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0297-2021
Classification
Class II
Status
Terminated
Recall initiated
Feb 15, 2021
FDA report date
Mar 10, 2021
Quantity
9,452 cartons
Recall type
Voluntary: Firm initiated
Recalling firm
Teva Pharmaceuticals USA

Original FDA data

Every field from FDA enforcement report D-0297-2021, exactly as published.

Show all FDA fields
City
Parsippany
State
NJ
Status
Terminated
Country
United States
Event ID
87330
Address
400 Interpace Pkwy
Code information
Lot # 31325335B, exp. date 07/2021
Postal code
07054-1120
Report date
Mar 10, 2021
Product type
Drugs
Recall number
D-0297-2021
Classification
Class II
Recalling firm
Teva Pharmaceuticals USA
Product quantity
9,452 cartons
Termination date
Aug 26, 2021
Reason for recall
Chemical contamination; Unknown brown residue adhering to the inside of one vial.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Metoclopramide Injection USP, 10 mg/2 mL (5 mg/mL), 25x2mL Single Dose Vials, Rx only, Distributed by Teva Pharmaceuticals, USA, Inc., Parsippany, NJ Vial NDC 0703-4502-01 (vial) NDC# 0703-4502-04 (tray)
Distribution pattern
Nationwide, including Puerto Rico
Recall initiation date
Feb 15, 2021
Initial firm notification
Letter
Center classification date
Mar 3, 2021

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0297-2021, published Mar 10, 2021. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls